THINGS TO KNOW ABOUT BEXSERO

It’s the first and only meningitis B vaccine that can be used in children under 10 years of age. BEXSERO is indicated for individuals 2 months through 25 years of age, to help protect against disease caused by Neisseria meningitidis group B strains (meningitis B).

It’s a vaccine that prevents meningococcal disease caused by meningitis B.*

BEXSERO helps provide protection against meningitis B,* that can cause serious, and sometimes life-threatening infections such as:

  • Meningitis (infection of the lining of the brain and spinal cord)
  • Sepsis (blood poisoning)

These infections require immediate medical attention.

DID YOU KNOW?

63% of invasive meningococcal disease cases in Canada were caused by meningitis B from 2011 through 2015.

Vaccination against meningitis B* is not part of your child’s routine vaccination schedule.
Help protect your child against meningococcal disease caused by meningitis B.* Find the clinic nearest you by using the clinic finder below.

BEXSERO is a vaccine, for individuals from 2 months through 25 years of age, for the prevention of meningococcal disease caused by the Neisseria meningitidis group B bacteria.

*Meningococcal disease caused by Neisseria meningitidis group B strains.

†BEXSERO does not treat or reduce the consequences of meningococcal meningitis, including meningitis, sepsis, and death.

‡Based on most recent data available.

Dosing

Depending on age, the doctor, pharmacist or nurse will inject BEXSERO into your child’s arm or leg muscle.

Recommended vaccination schedule:

Age group at time of first dose

Infants (Option 1)

2 through 5 months of age

Primary immunization

Primary doses

Each dose is 0.5 mL

2

Interval between primary doses

≥2 months

Booster dose

(0.5 mL)

1 dose

required in the 2nd year of life after an interval of ≥6 months from the last injection of the initial course.

Infants (Option 2)

2 through 5 months of age

Primary immunization

Primary doses

Each dose is 0.5 mL

3

Interval between primary doses

≥1 month

Booster dose

(0.5 mL)

1 dose

required in the 2nd year of life after an interval of ≥6 months from the last injection of the initial course.

Infants

6 through 11 months of age

Primary immunization

Primary doses

Each dose is 0.5 mL

2

Interval between primary doses

≥2 months

Booster dose

(0.5 mL)

1 dose

required in the 2nd year of life, after an interval of ≥2 months from the last dose. The need for further doses has not been established.

Children

12 months through 23 months

Primary immunization

Primary doses

Each dose is 0.5 mL

2

Interval between primary doses

≥2 months

Booster dose

(0.5 mL)

Need not established.

Children

2 years through 10 years of age

Primary immunization

Primary doses

Each dose is 0.5 mL

2

Interval between primary doses

≥1 month

Booster dose

(0.5 mL)

Need not established.

Adolescents and adults

11 through 25 years of age

Primary immunization

Primary doses

Each dose is 0.5 mL

2

Interval between primary doses

≥1 month

Booster dose

(0.5 mL)

Need not established.

To download this dosing schedule click on the button below.

Download this schedule

Make sure that your child gets all prescribed doses. This allows your child to get the full benefits of BEXSERO.

Don’t forget to sign up for the BEXSERO dose reminder tool that will let you know when your child’s next dose is due.

Potential side effects

Like all vaccines, BEXSERO may cause side effects, although not everybody gets them.

When BEXSERO is administered, the very common side effects (affecting >1 in 10 people) your child* may experience at the site of injection include:

  • pain/tenderness
  • redness of the skin
  • swelling of the skin
  • hardness of the skin

* Reported in all age groups 2 months through 25 years of age.

Side effects may also occur after receiving this vaccine.

Click to view side effects by age group:

Reporting a suspected side effect

If you need to report an adverse event, please call 1-800-387-7374.

Please note: Your healthcare professional is the best source of information regarding your health. You are advised to discuss the advantages and disadvantages of BEXSERO with your healthcare professional before receiving the vaccine.

For complete instructions, see the Consumer Information leaflet that comes with your BEXSERO prescription.